Fig. 3: In vivo PET/CT pharmacokinetics and biodistribution using 68Gallium labelled probes. | npj Imaging

Fig. 3: In vivo PET/CT pharmacokinetics and biodistribution using 68Gallium labelled probes.

From: Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis

Fig. 3

a Fused PET and CT images demonstrate the clearance pathway and segmentation of the organs for quantitative analysis. b, c Quantification of injected dose of the 68Ga-DOTAMA-CBP1 (b) and the 68Ga-DOTAMA-CBP2 (c) probes in the kidney, liver, and blood over time shows favourable pharmacokinetics. d Ex vivo radioactivity measurements show high kidney uptake and low uptake in all other tissues. T time post-injection (minutes).

Back to article page